NCDR PVI Registry (Peripheral Vascular Intervention Registry) v 2 Renal Artery Intervention Module- DRAFT ,,, Patient Restriction N683

Transcription

1 Page 1 of 12 A. DEMOGRAPHICS Last Name 2000 : First Name 2010 : Middle Name 2020 : SSN 2030 : - - SSN N/A 2031 Patient ID 2040 : Birth Date 2050 : Sex 2060 : O Male Race: (check all that apply) B. EPISODE OF CARE Arrival Date/Time 3000/3001 : Health Insurance 3005 : HIC # 3030 : HH:MM C. HISTORY AND RISK FACTORS (LEADING TO EPISODE OF CARE) O Female (auto) Other ID 2045 : White 2070 Black/African American 2071 American Indian/Alaskan Native 2073 Hispanic or Latino Ethnicity 2076 : Private Health Insurance Medicare Medicaid Military Health Care State-Specific Plan (non-medicaid) Indian Health Service Non-US Insurance Patient Zip Code 3005 : Zip Code N/A 3006 Asian 2072 If Yes, Asian - Indian 2080 Chinese 2081 Filipino 2082 Japanese 2083 Korean 2084 Vietnamese 2085 Other 2086 Native Hawaiian/Pacific Islander 2074 If Yes, Native Hawaiian 2090 Guamanian or Chamorro 2091 Samoan 2092 Other Island 2093 If Yes, Ethnicity Type: (Select all that apply) Mexican, Mexican-American, Chicano 2100 Puerto Rican 2101 Cuban 2102 Other Hispanic, Latino or Spanish Origin 2103 Admitting Provider Name, NPI 3050,3051,3052,3053 : Attending Provider Name, NPI 3055,3056,3057,3058 :,,, If Yes, Payment Source 3010 : Research Study 3035 : If Yes, Study Name 3036, Patient ID 3037 : (Select all that apply),,, Patient Restriction N683, Hypertension 4000 : If Yes, Cervical Involvement C104 : If Yes, Other Vascular Territory Involvement C105 : If Yes, select Treatment Type C101 : O New Onset medical management O Well controlled, on 2 anti-hypertensives O Uncontrolled, on < 3 anti-hypertensives O Uncontrolled, on 3 anti-hypertensives O Failure to control, on 3 maximally tolerated medications, one a diuretic Fibromuscular Dysplasia C102 : If Yes, Renal Involvement C103 : History of Renal Transplant C106 : If Yes, Right Kidney C107 : If Yes, Left Kidney C108 : If Yes, Currently On Dialysis 4020 : Renal Artery Dissection C109 : If Yes, Spontaneous C110 : If Yes, Associated with Aortic Dissection C111 : Chronic Kidney Disease C112 : Heart Failure 4080 : If Yes, NYHA Class 5210 : O Class I O Class II O Class III O Class IV Unexplained Sudden Onset Pulmonary Edema C113 : Chronic Lung Disease 4060 : Dyslipidemia 4005 : _ cm Height 4115 : Weight 4120 : Prior Valve Surgery/Procedure 4100 : Prior History of Arrhythmia 109 : Coronary Artery Disease 4025 : Prior Myocardial Infarction 4065 : If Yes, within 30 Days 4070 : PCI 4090 : CABG 4095 : Cardiomyopathy 107 : LV Systolic Dysfunction 108 : Pre-Procedure LVEF Assessed 5701 : If Yes, Pre-Procedure LVEF 5700 : Positive Cardiac Stress Test C114 : Diabetes Mellitus 4010 : _% _ kg If Yes, Diabetes Therapy c120 : None Diet Oral Insulin Other Tobacco Use 4105 : O Never O Former O Current - Every Day O Current - Some Days O Current - Frequency Unknown If any Current, Tobacco Type: 4626 (Select all that apply) Cigarettes Cigars Pipe Smokeless If Current Every Day and Cigarettes, Amount: 4627 O Light tobacco use (< 10/day) O Heavy tobacco use (>= 10/day)

2 C. HISTORY AND RISK FACTORS (CONT) Chest Pain Symptom Assessment N864 : Cerebrovascular Disease 4040 O Typical Angina O Atypical Angina n-anginal Chest pain O Asymptomatic Prior PAD Surgery 117: If Yes, Prior PAD Surgery Type/Side (Select all that apply) RIGHT LEFT Peripheral Intervention C121, C122 If Yes, Date C124 : If Yes, Date C125 : C126, C127 Peripheral Bypass If Yes, Date C128 : If Yes, Date C129 : Prior Renal Denervation C130, C131 : If Yes, Date C132 : If Yes, Date C133 : Renal Artery Stenting C134,C135 : If Yes, Date C136 : If Yes, Date C137 : RIGHT LEFT Kidney Pole Length C138,C139 : Atrophic Kidney C140,C141 : Renal Artery Stenosis C144,C145 : cm cm Solitary Functioning Kidney C142 : If Yes, Location C143 : O Right O Left D. PRESENTATION AND EVALUATION Ambulation Status 158 : functional limitations O Ambulates with assistive devices O Wheelchair/stretcher bound Pre-Admission Living Status 159 : CSHA Clinical Frailty Scale : O 1 = Very Fit O 2 = Well O 3 = Managing Well O Home Independent O Home with Caregiver O Skilled Nursing Facility O Homeless O Other O 4 = Vulnerable O 5 = Mildly Frail O 7 = Severely Frail O 8 = Very Severely Frail O 9 = Terminally Ill Renal Artery Duplex Ultrasound Performed D103, D104 : If Yes, Segment D105, D106 : If Yes, Peak Systolic Velocity in Lesion D107, D108 : If Yes, Peak Systolic Velocity Proximal To Lesion D109, D110 : If Yes, Renal/Aortic Ratio D100,D101 : If Yes, Peak Systolic Velocity Ratio D111, D112 : Renal Artery CT Angiography Performed D113, D114 : If Yes, Max Stenosed Segment D115, D116 : If Yes, Max Stenosis D117, D118 : Renal Artery MR Angiography Performed D119, D120 (Code : most severe segment If Yes, Max Stenosed Segment D121, D122 treated) : If Yes, Max Stenosis D123, D124 : (Code most severe segment treated) (Code most severe segment treated) RIGHT cm/sec cm/sec % % LEFT % cm/sec cm/sec % New Need for dialysis post-arrival D102 : 1 Canadian Study of Health and Aging Clinical Frailty Scale is Used with Permission For The American College of Cardiology Foundation By Dr. Kenneth Rockwood ( Kenneth Rockwood, MD) Page 2 of 12

3 Anticoagulants Antiplatelets Thrombolytics Other Thrombin Receptor Antagonist Heparin and Derivatives Direct Thrombin Inhibitors Direct Factor Xa Inhibitors VitK Ant P2Y12 Antagonists PCSK9 Inhibitor Page 3 of 12 I. PRE-PROCEDURE MEDICATIONS (ADMINISTERED WITHIN 24 HOURS PRIOR TO THE PROCEDURE, COMPLETE FOR EACH PROCEDURE TYPE) MEDICATION 7800 ADMINISTERED 7805 Low DOSAGE 961 Moderate High Fondaparinux Low Molecular Wt Heparin Unfractionated Heparin Heparin / Derivative (Other) Argatroban Bivalirudin Dabigatran Apixaban Edoxoban Rivaroxaban Direct Factor Xa Inhibitors (Other) Warfarin Aspirin Dipyridamole Glycoprotein IIb/IIIa Inhibitor (Any) Clopidogrel Prasugrel Ticagrelor Vorapaxar Alteplase Reteplase Streptokinase Tenecteplase Thrombolytic (Other) ACE-I ACE-Inhibitor (Any) ARB ARB (Any) Valsartan/Sacubitril Beta Blockers (Any) Calcium Channel Blockers (Any) Diuretics (Any) Vasodilators (Any) Statin Statin (Any) O O O Alirocumab Evolocumab PCSK9 Inhibitors (Any) PDE Inhibitor Phosphodiesterase Inhibitor (Any)

4 Page 4 of 12 E. PROCEDURE (COMPLETE FOR EACH PROCEDURE) Procedure Start Date/Time 6000/6001 : mm/dd/yyyy / hh:mm Procedure End Date/Time 6005/6006 : mm/dd/yyyy / hh:mm Operator Name 6015, 6020, 6025 : Operator NPI 6030 : Procedure Type 6010 : Location of Procedure 6038 : O Renal Artery Intervention O OR O Cath Lab O IR O Hybrid OR O Free-standing Clinic Procedure Status 6035 : O Elective O Urgent O Emergency Procedure Indication E108 : O Asymptomatic O Cardiac destabilization O Refractory hypertension O Pulmonary edema O Worsening renal failure O Preservation of transplanted kidney function O Complication after Prior Renal Denervation O Renal artery dissection O Associated with abdominal aortic intervention O Other If Procedure Indication = cardiac destabilization N831 : O New onset heart failure O Recurrent heart failure O Acute pulmonary edema O Unstable Angina If cardiac destabilization = Unstable Angina, 2 or more antianginal medications N832 : BP at start of Procedure E100, E101 : / mmhg Sedation 6050 O Minimal Sedation/Anxiolysis O Moderate Sedation/Analgesia (Conscious Sedation) O Deep Sedation/Analgesia O General Anesthesia Intra-Procedure Anticoagulants N180 : If Yes, Heparin N181 : If Yes, Direct Thrombin Inhibitor E107 : ARTERIAL ACCESS (COMPLETE FOR EACH PROCEDURE. CODE IN THE ORDER ATTEMPTED.) Site(s) 6200 Side 6205 Vessel E128 US Guided Access E129 Closure Method(s) 6220,25, O Right O Left O Right O Left O Femoral O Radial O Brachial O Femoral O Radial O Brachial UDI

5 Page 5 of 12 E. RENAL ARTERY INTERVENTION (COMPLETE FOR EACH INTERVENTION ATTEMPTED OR PERFORMED) Lesion Counter N726 : 1 2 Segment Number(s) N727 :,,,,,, Prev Treated Lesion N728 : If Yes, Timeframe N729 : O < 1 month O 1-5 months O 6-12 months O 1-2 years O >2 years O Time unknown N730 If Yes, Previous Rx E131 :(Select all that apply) PTA Atherectomy Stent If Prior Stent, Type N731 Stenosis Prior to Rx N732 : Stenosis hemodynamically significant (i.e %) N833 : Guidewire Across Lesion N733 : Lesion Length N734 : DEB Unknown O Coronary DES O Peripheral DES O Coronary BMS O Peripheral BMS O Balloon Expandable Covered O Self-expanding Covered O Resorbable Scaffold o Unknown % mm O < 1 month O 1-2 years mm O 1-5 months O >2 years O 6-12 months O Time unknown N730 PTA Atherectomy Stent DEB Unknown O Coronary DES O Peripheral DES O Coronary BMS O Peripheral BMS O Balloon Expandable Covered O Self-expanding Covered O Resorbable Scaffold o Unknown % Thrombus Present N735 : Dissection Present N736 : Bifurcation Lesion N737 : Ostial Lesion N738 : Baseline Pressure Gradient Performed N739 : If Yes, Rest Pressures N740, N741 : Aneurysm N750 : mmhg (p-p) mmhg (mean) If Yes, Hyperemia Pressures N742, N743 : mmhg (p-p) mmhg (mean) Post-procedure Pressure Gradient Perfomed N744 : If Yes, Rest Pressures N745, N746 : If Yes, Hyperemia Pressures N747, N748 : Agent(s) used for Hyperemia N749 : (Select all that apply) If Yes, Max Diameter N751 : If Yes, Morphology N752 : mmhg (p-p) mmhg (mean) mmhg (p-p) mmhg (mean) O N/A O Dopamine O Papaverine O Nitroglycerin O Verapamil O Adenosine O Other mm O Fusiform O Saccular mmhg (p-p) mmhg (mean) mmhg (p-p) mmhg (mean) mmhg (p-p) mmhg (mean) mmhg (p-p) mmhg (mean) O N/A O Dopamine O Papaverine O Nitroglycerin O Verapamil O Adenosine O Other mm O Fusiform O Saccular If Yes, Course N753 : Final Stenosis N754 : Renal Denervation N755 : If Yes, Part of Study N756 : If Yes, Number of Burns N757 : If Yes, Watts Used N758 : O Stable % O Enlarging O Stable % W W O Enlarging If Yes, Location of Burns N759 : O Main Renal Artery O Segmental Branch O Main Renal Artery O Segmental Branch

6 Page 6 of 12 E. RENAL ARTERY INTERVENTION (COMPLETE FOR EACH PROCEDURE) LIST ALL DEVICES IN CHRONOLOGICAL ORDER: N766, N767 Device(s) Used UDI Associated Lesion(s) N768 (Specify Lesion Counter, Seq. N726) Device Activated N769 N770-N ,,,,,, Procedure Treatment Incomplete or Aborted N760 : If Yes, Reason(s) Treatment Aborted: (Select all that apply) N761, N762 Right Failure to gain vascular access Hypotension Hypertension Arrhythmia Cardiac ischemia Other Left Failure to gain vascular access Hypotension Hypertension Arrhythmia Cardiac ischemia Other Lesion Treatment Incomplete or Aborted N763 Right Left If Yes, Reason(s) Treatment Aborted: N764, N765 (Select all that apply) Failure to confirm significant stenosis Unable to place guide catheter/sheath Unable to deliver stent Unable to deploy stent Difficult to access due to tortuosity Unable to cross guidewire Unable to cross balloon Other Failure to confirm significant stenosis Unable to place guide catheter/sheath Unable to deliver stent Unable to deploy stent Difficult to access due to tortuosity Unable to cross guidewire Unable to cross balloon Other L. POST-PROCEDURE ASSESSMENT (COMPLETE FOR EACH PROCEDURE, ONLY FOR THE TARGET VESSEL SIDE(S) AFFECTED) RIGHT LEFT Renal Artery Duplex Ultrasound N777, N778 : If Yes, Segment N779, N780 : (Code most severe segment treated) N781, N782 If Yes, Peak Systolic Velocity in Lesion If Yes, Peak Systolic Velocity Proximal To Lesion N783, N784 : cm/sec cm/sec cm/sec cm/sec If Yes, Renal/Aortic Ratio N785, N786 : If Yes, Peak Systolic Velocity Ratio N787, N788 : Renal Artery CT Angiography Performed N789, N790 : If Yes, Max Stenosed Segment N791, N792 : If Yes, Max Stenosis N793, N794 : Renal Artery MR Angiography Performed N795, N796 : If Yes, Max Stenosed Segment N797, N798 : If Yes, Max Stenosis N799, N800 : (Code most severe segment treated) (Code most severe segment treated) % % % %

7 J. PROCEDURE TOTALS (COMPLETE FOR EACH PROCEDURE) Contrast Volume 8000 : _ ml Fluoro Time 8005 : _ minutes CO2 Used N456 : Cumulative Air Kerma 900 : O mgy O Gy Dose Area Product 901 : O Gy-cm 2 O dgy-cm 2 O cgy-cm 2 O mgy-cm 2 O µgy-m 2 Estimated Procedural Blood Loss 906 ml K. LABS (COMPLETE FOR EACH PROCEDURE) Pre-Procedure Lowest Creatinine in 6-12 months prior to procedure N773 : Creatinine 8100 mg/dl N774, N775 mm/dd/yyyy / hh:mm mg/dl mm/dd/yyyy / hh:mm 8101/8102 Unavailable N776 Not Drawn 8105 Post-Procedure (post-procedure only) Creatinine 8130 Hemoglobin 8140 mg/dl Not Drawn 8135 mm/dd/yyyy / hh:mm 8131/8132 g/dl Not Drawn 8145 (lowest value w/in 72 hrs) mm/dd/yyyy / hh:mm 8141/8142 Hemoglobin 8110 HbA1c 902 : LDL 8120 g/dl Not Drawn 8115 mm/dd/yyyy / hh:mm 8111/8112 % Not Drawn , 904 mm/dd/yyyy / hh:mm mg/dl Not Drawn 8125 mm/dd/yyyy / hh:mm 8121/8122 M. INTRA OR POST-PROCEDURE EVENTS (COMPLETE FOR EACH PROCEDURE TYPE) CARDIOVASCULAR Event Event Occurred Event Date(s) Myocardial Infarction 8400 : mm/dd/yyyy / hh:mm 704 Cardiac Arrest 705 : mm/dd/yyyy / hh:mm 706 Heart Failure 8410 : mm/dd/yyyy / hh:mm 708 PULMONARY Unexpected intubation 721 : mm/dd/yyyy / hh:mm 722 Pneumonia 723 : mm/dd/yyyy / hh:mm 724 NEUROLOGIC TIA 8425 : 713 Ischemic Stroke 8430 : 714 Hemorrhagic Stroke Undetermined Stroke 8440 : 716 Page 7 of 12

8 M. INTRA OR POST-PROCEDURE EVENTS (CONTINUED) SYSTEMIC Event Event Occurred Event Date(s) Thrombosis 8475 : mm/dd/yyyy / hh:mm N342 Embolism 8480 : mm/dd/yyyy / hh:mm N343 Persistent Hypotension >24h Requiring Rx 8415 : mm/dd/yyyy / hh:mm 709 Anaphylactoid Contrast Reaction 8525 : mm/dd/yyyy / hh:mm 739 VASCULAR Significant Dissection 8485 : mm/dd/yyyy / hh:mm 725 Perforation 8490 : mm/dd/yyyy / hh:mm 726 Other Vascular Complication Req Treatment 8500 : mm/dd/yyyy / hh:mm 728 Abrupt Vessel Closure N801 mm/dd/yyyy / hh:mm N802 Renal Capsular Hematoma N803 : mm/dd/yyyy / hh:mm N804 GENITOURINARY AND GASTROINTESTINAL New Requirement for Dialysis 8465 : mm/dd/yyyy / hh:mm 720 INFECTION Procedure-Related Infection Req Antibiotics 8530 : mm/dd/yyyy / hh:mm 745 BLEEDING Bleeding Event w/in 72 Hours 8535 : mm/dd/yyyy / hh:mm N344 If Yes, Bleeding at Access Site 8540 : If Yes, Access Bleed Location 8545 : mm/dd/yyyy / hh:mm N345 Use Access Site ID / Seq. Num 6200:,, If Yes, Hematoma at Access Site 8550 : If Yes, Access Hematoma Location 8555 : Use Access Site ID / Seq. Num 6200:,, mm/dd/yyyy / hh:mm N346 If Yes, Retroperitoneal Bleeding 8560 : mm/dd/yyyy / hh:mm N347 If Yes, GI Bleed 8565 : mm/dd/yyyy / hh:mm N348 If Yes, GU Bleed 8570 : mm/dd/yyyy / hh:mm N349 If Yes, Other Bleed 8575 : mm/dd/yyyy / hh:mm N350 RBC/Whole Blood Transfusion 8580 : mm/dd/yyyy / hh:mm 746 If Yes, Hgb Prior to 1 st Transfusion 8585 : mg/dl If Yes, Number of units Transfused 747 : units Page 8 of 12

9 Page 9 of 12 N. DISCHARGE (COMPLETE FOR EACH EPISODE OF CARE) Discharge Date 9000 : Discharge Status 9005 : O Alive If Alive, Discharge Location 9010 : HH:MM Discharging Provider Name, NPI 10070,10071,10072,10073 : O Deceased If Alive and Current Tobacco User, Cessation Counseling 9020 : If Deceased, Cause of Death 9030 : O Home O Extended Care/TCU/rehab If Alive, Hospice Care 9015 : If Deceased, Death During Procedure 9025 :,,, O Transfer to other acute care hospital O Skilled Nursing Facility O Other O Left AMA O Acute myocardial infarction O Pulmonary O Hemorrhage O Sudden cardiac death O Renal n-cardiovascular procedure or surgery O Heart failure O Gastrointestinal O Trauma O Stroke O Hepatobiliary O Suicide O Cardiovascular procedure O Pancreatic O Neurological O Cardiovascular hemorrhage O Infection O Malignancy O Other cardiovascular reason O Inflammatory/Immunologic O Other non-cardiovascular reason Discharge Ambulation Status 907 : functional limitations O Ambulates with assistive devices O Wheelchair/stretcher bound

10 Anticoagulants Antiplatelets Thrombin Inhibitors Direct Factor Xa Inhibitors VitK Ant P2Y12 Antagonists Page 10 of 12 N. DISCHARGE (CONTINUED) DISCHARGE MEDICATIONS Discharge medications are not required for patients who expired, discharged to Other acute care Hospital, AMA, or are receiving Hospice Care. ACE-I ARB Beta Blocker Statin PDE Inhibitor PCSK9 Inhibitor Medication 9500 Dabigatran Direct Thrombin Inhibitor (Other) Apixaban Rivaroxaban Direct Factor Xa Inhibitor (Other) Warfarin Aspirin Dipyridamole Clopidogrel Prasugrel Ticagrelor P2Y12 Antagonist (Other) ACE-Inhibitor (Any) ARB (Any) Beta Blocker (Any) Statin (Any) PDE Inhibitor (Any) Alirocumab Evolocumab PCSK9 Inhibitors (Any) Prescribed at Discharge 9505 No No No Medical No-Patient Yes Reason Reason Reason Dose 908 Moderate High O O O Low IF NO - PT. REASON, PATIENT RATIONALE Discharge: Medication Reconciliation Completed If Yes, Medications Reconciled Include: (Select all that apply) Prescriptions: Cardiac Prescription: Non Cardiac Non Prescription (OTC) Medications Vitamins / Minerals Herbal Supplements

11 O. FOLLOW-UP (30 DAYS POST INDEX PROCEDURE: +/- 7 DAYS AND 1 YEAR POST INDEX PROCEDURE: +/- 60 DAYS) Assessment Date : Reference Procedure Start Date/Time 10001/10002 : mm/dd/yyyy / hh:mm Method(s) to Determine Status 912 (Select all that apply) Follow-up Status : If Deceased, Date of Death : If Deceased, Cause of Death : Office Visit Medical Records Letter from Medical Provider Phone Call Social Security Death Master File Hospitalized Other O Alive O Deceased O Lost to Follow-up Reference Episode Arrival Date/Time xxxx : mm/dd/yyyy / hh:mm Reference Episode Discharge Date/Time xxxx : mm/dd/yyyy / hh:mm O Acute myocardial infarction O Pulmonary O Hemorrhage O Sudden cardiac death O Renal n-cardiovascular procedure or surgery O Heart failure O Gastrointestinal O Trauma O Stroke O Hepatobiliary O Suicide O Cardiovascular procedure O Pancreatic O Neurological O Cardiovascular hemorrhage O Infection O Malignancy O Other cardiovascular reason O Inflammatory/Immunologic O Other non-cardiovascular reason O. CLINICAL ASSESSMENT AT FOLLOW-UP (30 DAYS POST INDEX PROCEDURE: +/- 7 DAYS AND 1 YEAR POST INDEX PROCEDURE: +/- 60 DAYS) Follow-Up Ambulation Status 913 : functional limitations O Ambulates with assistive devices O Wheelchair/stretcher bound Follow-Up Living Status 914 : Follow-Up CSHA Clinical Frailty Score : O Home Independent O Home with Caregiver O Skilled Nursing Facility O Homeless O Other O 1 = Very Fit O 2 = Well O 3 = Managing Well O 4 = Vulnerable O 5 = Mildly Frail O 6 = Moderately Frail O 7 = Severely Frail O 8 = Very Severely Frail O 9 = Terminally Ill Refractory Hypertension N805 : If Yes, select Treatment Type N806 : O New Onset medical management O Well controlled, on 2 anti-hypertensives O Uncontrolled, on < 3 anti-hypertensives O Uncontrolled, on 3 anti-hypertensives O Failure to control, on 3 maximally tolerated medications, one a diuretic RIGHT LEFT Renal Artery Duplex Ultrasound N807, N808 : If Yes, Segment N809, N810 : (Code most severe location) If Yes, Peak Systolic Velocity in Lesion N811, N812 : If Yes, Peak Systolic Velocity Proximal To Lesion N813, N814 : If Yes, Renal/Aortic Ratio N815, N816 : If Yes, Peak Systolic Velocity Ratio N817, N818 : cm/sec cm/sec cm/sec cm/sec Renal Artery CT Angiography Performed N819, N820 : If Yes, Max Stenosed Segment N821, N822 (Code most severe : location treated) If Yes, Max Stenosis N823, N824 : % % Renal Artery MR Angiography Performed N825, N826 : If Yes, Max Stenosed Segment N827, N828 : If Yes, Max Stenosis N829, N830 : (Code most severe location treated) % % 1 Canadian Study of Health and Aging Clinical Frailty Scale is Used with Permission For The American College of Cardiology Foundation By Dr. Kenneth Rockwood ( Kenneth Rockwood, MD) Page 11 of 12

12 Page 12 of 12 O. FOLLOW-UP (CONTINUED) EVENTS SINCE DISCHARGE Readmitted : If Yes, Related to procedure N367 : O Indeterminate If Yes, Readmission Length of Stay : days If Yes, Readmission Date : If Yes, Hospitalized at time of Follow-up : EVENT EVENT OCCURRED EVENT DATE(S) CARDIOVASCULAR Myocardial Infarction : 933 NEUROLOGIC Ischemic Stroke : 934 Hemorrhagic Stroke : 935 Undetermined Stroke : 936 VASCULAR Major Vascular Complication : Lower Extremity Vascular Intervention : If Yes 949 : O Right O Left O Bilateral Surgical Revascularization : If Yes 958 : O Right O Left O Bilateral Endovascular Intervention 945 : If Yes 947 : O Right O Left O Bilateral Target Vessel Revascularization : Thrombectomy/Lysis Revision 954 : If Yes 956 : O Endovascular O Surgical RENAL O Both New Requirement for Dialysis : 944 INFECTION Surgical Site Infection 941 : If Yes, Surgical Site Infection Type 943 : O Superficial O Deep O Organ Space 942 BLEEDING Life Threatening Bleeding : 938 FOLLOW-UP, LABS SINCE DISCHARGE Creatinine N368 mg/dl Not Drawn N369